Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.6813
-0.0187 (-2.67%)
Jun 29, 2026, 12:37 PM EDT - Market open
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $27.83 million as of June 29, 2026. Its market cap has decreased by -28.13% in one year.
Market Cap
27.83M
Enterprise Value
-26.78M
1-Year Change
-28.13%
Ranking
Category
Stock Price
$0.68
Market Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $27.83M, a decrease of -95.19%. That is a compound annual growth rate of -44.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 27.83M | -2.64% |
| Dec 31, 2025 | 28.59M | -41.18% |
| Dec 31, 2024 | 48.60M | -65.85% |
| Dec 29, 2023 | 142.31M | 62.36% |
| Dec 30, 2022 | 87.65M | -77.38% |
| Dec 31, 2021 | 387.51M | -33.08% |
| Apr 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lisata Therapeutics | 30.60M |
| Lite Strategy | 30.55M |
| NanoViricides | 30.53M |
| GridAI Technologies | 29.34M |
| Tevogen Bio Holdings | 29.31M |
| Kyntra Bio | 29.31M |
| Dyadic International | 29.19M |
| Plus Therapeutics | 28.91M |